Immunology
Showing page 161 of 175 pages of list content
-
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
This article's authors -
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
This article's authors -
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity
This article's authors -
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory
This article's authors -
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
This article's authors -
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
This article's authors -
A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells
This article's authors -
Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of inhibiting SARS-CoV-2 replication and induced inflammation
This article's authors -
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
This article's authors -
SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8
This article's authors